GS
INSY

GAM Systematic’s Insys Therapeutics, Inc. INSY Stock Holding History

GAM Systematic’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-15,180
Closed -$179K – 693
2016
Q3 		$179K Buy
+15,180
New +$231K 0.04% 512
2016
Q2 		– Sell
-163
Closed -$3K – 704
2016
Q1 		$3K Sell
163
-2,652
-94% -$50.4K ﹤0.01% 611
2015
Q4 		$81K Buy
2,815
+2,479
+738% +$68.7K 0.02% 553
2015
Q3 		$10K Buy
+336
New +$12.4K ﹤0.01% 609

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GAM Systematic's INSY Position: Q4 2016 in Review

GAM Systematic sold out of Insys Therapeutics, Inc. (INSY) in Q4 2016, closing a stake of 15,180 shares — an estimated $179K sold.

GAM Systematic first reported a position in INSY in Q3 2015 and held it in 4 quarters. The position peaked at $179K in Q3 2016. 138 funds tracked by Wall St. Rank hold INSY as of Q4 2016.

  • GAM Systematic reported no remaining Insys Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • GAM Systematic sold 15,180 Insys Therapeutics, Inc. shares in Q4 2016, an estimated $179K.
  • GAM Systematic first reported a position in Insys Therapeutics, Inc. in Q3 2015 and held it in 4 quarters.
  • GAM Systematic's Insys Therapeutics, Inc. position peaked at $179K in Q3 2016.
  • 138 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2016.

Based on GAM Systematic's 13F filing for Q4 2016, filed 14 Feb 2017.